Cargando…

Salvianolic acid D: A potent molecule that protects against heart failure induced by hypertension via Ras signalling pathway and PI3K/Akt signalling pathway

ETHNOPHARMACOLOGICAL RELEVANCE: Salvianolic acid D (Sal D) is a natural substance extracted from Radix Salviae that performs a cardiovascular benefit. However, the protective mechanism of Sal-D for heart failure remains uncertain. AIM OF THE STUDY: In this study, we aim to evaluate the effect of Sal...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kai, Guan, Yiqing, Wu, Shaoyu, Quan, Dongling, Yang, Danni, Wu, Huanxian, LV, Lin, Zhang, Guohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941879/
https://www.ncbi.nlm.nih.gov/pubmed/36825182
http://dx.doi.org/10.1016/j.heliyon.2022.e12337
Descripción
Sumario:ETHNOPHARMACOLOGICAL RELEVANCE: Salvianolic acid D (Sal D) is a natural substance extracted from Radix Salviae that performs a cardiovascular benefit. However, the protective mechanism of Sal-D for heart failure remains uncertain. AIM OF THE STUDY: In this study, we aim to evaluate the effect of Sal D on heart failure and elucidate its underlying mechanisms. MATERIALS AND METHODS: Using the spontaneously hypertensive rats (SHR) as a cardiac remodelling model, the cardioprotective effect of Sal D was evaluated. Employing bioinformatics analysis, the related mechanisms of Sal D treatment on heart failure were identified and validated by Western blot and polymerase chain reaction. RESULTS: The results showed that Sal D significantly improved cardiac function and attenuated cardiac hypertrophy. Besides, Sal D impaired mitochondrial structure and restored the energy charge of cardiomyocytes managed by angiotensin II. Bioinformatics analysis suggested that Sal D might improve heart failure by modulating the Ras and PI3K/AKT signalling pathways verified in vitro and in vivo. CONCLUSION: In summary, Sal D can improve the heart function of SHR by inhibiting the Ras signalling pathway and activating the PI3K/AKT signalling pathway.